For a new drug application (NDA/BLA), include the TR 82 data in Module 3 (Quality). For existing products, be prepared for a Standards of Care expectation during the next FDA or EMA audit.
Based on the guidelines outlined in TR 82, we recommend the following: pda technical report 82
Operators must define the parameters:
TR 82 bridges the gap between engineering theory and practical reality. It acknowledges that while high-velocity turbulent flow is preferred, effective thermal sanitization is still achievable at lower velocities if specific temperature mapping and validation protocols are followed. For a new drug application (NDA/BLA), include the
But in 2013, researchers noticed something alarming: in certain biologics, the endotoxin they added simply disappeared during storage. It wasn’t gone; it was It acknowledges that while high-velocity turbulent flow is
The , titled "Low Endotoxin Recovery," is a foundational industry document published in 2019 that addresses the phenomenon of endotoxin masking in pharmaceutical formulations. Key Focus: Low Endotoxin Recovery (LER)
